Bram Vanparys

Directeur/Membre du Conseil chez

Capricorn Health-Tech Fund NV

Health Technology

Finance

Consumer Services

Profil

Dr. Bram Vanparys is on the Board of Directors at Imcheck Therapeutics SAS, iSTAR Medical SA, Capricorn Health-Tech Fund NV, Kinaset Therapeutics, Inc. and Topas Therapeutics GmbH.
Dr. Vanparys was previously employed as a Partner by Gimv (Private Equity), an Investment Manager by Participatiemaatschappij Vlaanderen NV, a Research Analyst by KBC Asset Management NV, an Investment Analyst by KBC Private Equity NV, a Non-Executive Director by Multiplicom NV, and a Chairman by Q-Biologicals NV.
He also served on the board at Merck Ventures BV and Cartagenia NV.
He received his graduate degree from Ghent University, an MBA from Vlerick Leuven Gent Management School and a doctorate degree from Ghent University.

Postes actifs de Bram Vanparys

Sociétés	Poste	Début
Capricorn Health-Tech Fund NV Capricorn Health-Tech Fund NV Investment ManagersFinance Functions as a private equity fund	Directeur/Membre du Conseil	-
Imcheck Therapeutics SAS Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research	Directeur/Membre du Conseil	04/12/2019
iSTAR Medical SA iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions	Directeur/Membre du Conseil	01/01/2019
Topas Therapeutics GmbH Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for immune tolerance	Directeur/Membre du Conseil	-
Kinaset Therapeutics, Inc. Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases	Directeur/Membre du Conseil	-

Tous les postes actifs de Bram Vanparys

Anciens postes connus de Bram Vanparys

Sociétés	Poste	Fin
Gimv (Private Equity) Gimv (Private Equity) Investment ManagersFinance Gimv invests in small and middle market companies located in Benelux region and France. The firm focuses on sectors such as consumer, healthcare, smart industries and sustainable cities. It participates in growth stage capital requirements with an investment size of EUR 5 - 75 million.	Private Equity Investor	01/02/2026
Participatiemaatschappij Vlaanderen NV Participatiemaatschappij Vlaanderen NV Investment ManagersFinance PMV invests in companies located in Belgium. The firm focuses on a broad range of sectors and industries. It participates in equity and debt in seed stage, early stage, late stage and growth stage transactions with an investment size up to EUR 20 million. It consider minority investments and also makes co-investments.	Private Equity Investor	01/11/2015
KBC Private Equity NV KBC Private Equity NV Investment ManagersFinance KBC Private Equity is an active, long-term manager which typically invests between €2 million and €50 million in medium-sized unlisted companies primarily in Belgium, Central and Eastern Europe. The firm targets performing businesses in diverse sectors which usually demonstrate a positive EBITDA of at least €1.5 million, focusing on companies which have built up a leading position in a specific sector and which have identified growth opportunities. Specific criteria apply for investments in the biotech industry. The firm takes both majority and minority interests in companies, partnering with the other shareholders and investee company management. In addition to providing equity and/or mezzanine financing, they aim to create value in areas where they are skilled, without participating in the day-to-day operational policy of the investee company. KBC Private Equity generally seeks a seat on the Board of Directors. The firm aims to contribute to investee companies by evaluating their internal and external growth opportunities, optimizing their financial structure, introducing new customer and supplier relationships, improving reporting systems and sharing specific industry knowledge. Their typical holding period is five to seven years for most of their investment projects.	Analyste en capital-investissement	01/07/2010
Multiplicom NV Multiplicom NV Medical SpecialtiesHealth Technology Operates a quality management system to design, develop, manufacture and distribute CE-IVD products	Directeur/Membre du Conseil	-
░░░░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-

Voir l'expérience en détail de Bram Vanparys

Formation de Bram Vanparys

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Bram Vanparys

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	14
KBC Asset Management NV KBC Asset Management NV Investment ManagersFinance KBC AM is an active manager which invests in equity and fixed-income without following any particular investment style. They are also a passive manager for certain asset classes or portfolios. Within the group, the firm defines the investment strategy and undertakes a large part of the group's investment product development. They are also a competence center, contributing the bulk of the group's economic research. Research teams combine in-house research with outsourced investment intelligence to obtain risk estimates for all asset classes in which the firm invests. KBC AM’s investment process is primarily top-down. They first seek to identify market trends, then tactically allocate assets within a previously defined strategic framework and construct portfolios, aided by a qualitative bottom-up overlay.	Finance
Participatiemaatschappij Vlaanderen NV Participatiemaatschappij Vlaanderen NV Investment ManagersFinance PMV invests in companies located in Belgium. The firm focuses on a broad range of sectors and industries. It participates in equity and debt in seed stage, early stage, late stage and growth stage transactions with an investment size up to EUR 20 million. It consider minority investments and also makes co-investments.	Finance
Gimv (Private Equity) Gimv (Private Equity) Investment ManagersFinance Gimv invests in small and middle market companies located in Benelux region and France. The firm focuses on sectors such as consumer, healthcare, smart industries and sustainable cities. It participates in growth stage capital requirements with an investment size of EUR 5 - 75 million.	Finance
Ghent University Ghent University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
KBC Private Equity NV KBC Private Equity NV Investment ManagersFinance KBC Private Equity is an active, long-term manager which typically invests between €2 million and €50 million in medium-sized unlisted companies primarily in Belgium, Central and Eastern Europe. The firm targets performing businesses in diverse sectors which usually demonstrate a positive EBITDA of at least €1.5 million, focusing on companies which have built up a leading position in a specific sector and which have identified growth opportunities. Specific criteria apply for investments in the biotech industry. The firm takes both majority and minority interests in companies, partnering with the other shareholders and investee company management. In addition to providing equity and/or mezzanine financing, they aim to create value in areas where they are skilled, without participating in the day-to-day operational policy of the investee company. KBC Private Equity generally seeks a seat on the Board of Directors. The firm aims to contribute to investee companies by evaluating their internal and external growth opportunities, optimizing their financial structure, introducing new customer and supplier relationships, improving reporting systems and sharing specific industry knowledge. Their typical holding period is five to seven years for most of their investment projects.	Finance
Vlerick Leuven Gent Management School Vlerick Leuven Gent Management School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Capricorn Health-Tech Fund NV Capricorn Health-Tech Fund NV Investment ManagersFinance Functions as a private equity fund	Finance
Cartagenia NV Cartagenia NV Packaged SoftwareTechnology Services Provides software and database systems to genetic labs and clinicians	Technology Services
Multiplicom NV Multiplicom NV Medical SpecialtiesHealth Technology Operates a quality management system to design, develop, manufacture and distribute CE-IVD products	Health Technology
Q-Biologicals NV Q-Biologicals NV BiotechnologyHealth Technology Provides process development and biomanufacturing services	Health Technology
iSTAR Medical SA iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions	Health Technology
Topas Therapeutics GmbH Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for immune tolerance	Health Technology
Imcheck Therapeutics SAS Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research	Health Technology
Kinaset Therapeutics, Inc. Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases	Health Technology